Author of the publication

Medical students' exposure to and attitudes about the pharmaceutical industry: a systematic review.

, , and . PLoS medicine, 8 (5): e1001037 (May 2011)6165<m:linebreak></m:linebreak>M3: doi:10.1371/journal.pmed.1001037;.
DOI: 10.1371/journal.pmed.1001037

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information., , , , and . Medical care, 45 (10 Supl 2): S158-65 (October 2007)6354<m:linebreak></m:linebreak>LR: 20091118; GR: R01 023178/PHS HHS/United States; GR: R01 AG023178-03/AG/NIA NIH HHS/United States; JID: 0230027; 0 (Anti-Inflammatory Agents, Non-Steroidal); RF: 46; NIHMS40822; OID: NLM: NIHMS40822; OID: NLM: PMC2265540; ppublish;<m:linebreak></m:linebreak>CER.Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetes., , , , , and . Diabetes care, (xx 10 2006)10.2337/dc06-0570.Gerios: Recommending Drugs and Dosing for Elderly Patients., , , , and . AMIA, AMIA, (2002)Designing comparative effectiveness research on prescription drugs: lessons from the clinical trial literature., , and . Health affairs (Project Hope), 29 (10): 1842-8 (October 2010)CER; Recerca clínica; Introductori.Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study., , , and . American journal of epidemiology, 172 (7): 843-54 (October 2010)5732<m:linebreak></m:linebreak>JID: 7910653; aheadofprint;<m:linebreak></m:linebreak>Propensity score.A randomized study of how physicians interpret research funding disclosures., , , , , , , , and . The New England journal of medicine, 367 (12): 1119-27 (September 2012)6941<m:linebreak></m:linebreak>GR: 2R25CA092203-08/CA/NCI NIH HHS/United States; GR: K08HS18465-01/HS/AHRQ HHS/United States; JID: 0255562; CIN: N Engl J Med. 2012 Sep 20;367(12):1152-3. PMID: 22992081; ppublish;<m:linebreak></m:linebreak>Publicació; Interpretació de resultats; Indústria; RCT.High-dimensional propensity score adjustment in studies of treatment effects using health care claims data., , , , , and . Epidemiology (Cambridge, Mass.), 20 (4): 512-22 (July 2009)5216<m:linebreak></m:linebreak>GR: R01-AG018833/AG/NIA NIH HHS/United States; GR: R01-AG021950/AG/NIA NIH HHS/United States; GR: R01-AG023178/AG/NIA NIH HHS/United States; GR: R01-AG027400/AG/NIA NIH HHS/United States; GR: R01-MH078708/MH/NIMH NIH HHS/United States; JID: 9009644; CIN: Epidemiology. 2009 Jul;20(4):523-4. PMID: 19525688; ppublish;<m:linebreak></m:linebreak>Propensity score.Medical students' exposure to and attitudes about the pharmaceutical industry: a systematic review., , and . PLoS medicine, 8 (5): e1001037 (May 2011)6165<m:linebreak></m:linebreak>M3: doi:10.1371/journal.pmed.1001037;.